Previsioni sul mercato degli oppioidi in Europa fino al 2030 - Analisi regionale - per prodotto (oppioide a rilascio immediato a breve durata d\'azione e oppioide a rilascio prolungato a lunga durata d\'azione), applicazione (gestione del dolore, anestesia, soppressione della diarrea, soppressione della tosse, disassuefazione e altri), via di somministrazione (orale, iniettabile e cerotto transdermico) e canale di distribuzione (farmacie ospedaliere e farmacie al dettaglio)
L\'aumento dell\'incidenza del dolore cronico guida il mercato europeo degli oppioidi
Malattie croniche come malattie cardiovascolari, cancro, malattie muscoloscheletriche e malattie neurovascolari influenzano in modo critico la salute di una persona abbassando l\'immunità. Inoltre, molti pazienti che soffrono di queste condizioni soffrono di dolore cronico. Le malattie sopra menzionate sono più comuni negli adulti e nella popolazione geriatrica. Tuttavia, i casi di queste malattie stanno aumentando notevolmente anche tra i bambini. Il dolore cronico è comune anche tra sportivi, atleti e individui che vivono con infortuni passati. Secondo uno studio pubblicato nel NCBI (ovvero, National Center for Biotechnology Information), il 20% degli adulti soffre di dolore in tutto il mondo e il 10% riceve una nuova diagnosi di dolore cronico ogni anno. Mentre il dolore colpisce tutte le popolazioni, indipendentemente da sesso, razza/etnia, reddito, età o geografia, non è distribuito equamente in tutto il mondo. Gli oppioidi da prescrizione, tra cui idrocodone, ossicodone e morfina, sono potenti farmaci antidolorifici utilizzati per trattare il dolore causato da lesioni, interventi chirurgici e condizioni di salute come cancro e artrite. L\'aumento delle pratiche di prescrizione di oppioidi può essere attribuito ai programmi di rimborso assicurativo che incentivano gli oppioidi rispetto ai trattamenti alternativi del dolore, alle strutture dei costi che incoraggiano cure più efficienti e alle valutazioni che combinano la soddisfazione del paziente con un\'efficace gestione del dolore. Pertanto, a causa del vantaggio degli oppioidi nella gestione del dolore, la domanda è in aumento tra i pazienti con malattie croniche.
Panoramica del mercato degli oppioidi in Europa
Il mercato degli oppioidi in Europa è suddiviso in Germania, Regno Unito, Francia, Italia, Spagna e resto d\'Europa. L\'Europa occupa una posizione significativa nel mercato degli oppioidi in Europa e si prevede che registrerà una forte crescita del mercato durante il periodo di previsione. La crescita del mercato nella regione è principalmente attribuita alla crescente prevalenza di malattie che causano dolore cronico (come artrite, lombalgia e fibromialgia) e alla crescente disponibilità di farmaci per curare la dipendenza da farmaci oppioidi (come l\'eroina). Ad esempio, il metadone è l\'agonista degli oppioidi più prescritto in Europa e viene utilizzato nel 75% dei pazienti per il trattamento di mantenimento con agonisti degli oppioidi. La buprenorfina è il secondo agonista degli oppioidi più utilizzato nella regione. Tuttavia, è uno dei trattamenti di mantenimento con oppioidi più utilizzati in Croazia, Cipro, Repubblica Ceca, Finlandia, Francia e Svezia. La codeina è il principale agonista utilizzato a Cipro e in Germania, mentre la diacetilmorfina è quella comunemente utilizzata in Belgio, Danimarca, Germania, Paesi Bassi, Spagna, Regno Unito e Irlanda.
Fatturato e previsioni del mercato degli oppioidi in Europa fino al 2030 (milioni di $ USA)
Segmentazione del mercato degli oppioidi in Europa
Il mercato degli oppioidi in Europa è suddiviso in prodotto, applicazione, via di somministrazione, canale di distribuzione e paese.
In base al prodotto, il mercato degli oppioidi in Europa è suddiviso in oppioidi a rilascio immediato e breve durata d\'azione e oppioidi a rilascio prolungato e lunga durata d\'azione. Il segmento degli oppioidi a rilascio immediato e breve durata d\'azione ha detenuto una quota di mercato maggiore nel 2022. L\'oppioide a rilascio immediato e breve durata d\'azione è ulteriormente suddiviso in ossicodone, idrocodone, tramadolo, codina, propossifene e altri. L\'oppioide a rilascio prolungato e lunga durata d\'azione è ulteriormente suddiviso in ossicodone, fentanil, morfina, metadone e altri.
In termini di applicazione, il mercato europeo degli oppioidi è suddiviso in gestione del dolore, anestesia, soppressione della diarrea, soppressione della tosse, de-dipendenza e altri. Il segmento della gestione del dolore ha detenuto la quota di mercato maggiore nel 2022.
In base alla via di somministrazione, il mercato europeo degli oppioidi è suddiviso in cerotto orale, iniettabile e transdermico. Il segmento orale ha detenuto la quota di mercato maggiore nel 2022.
In base al canale di distribuzione, il mercato europeo degli oppioidi è suddiviso in farmacie ospedaliere e farmacie al dettaglio. Il segmento delle farmacie ospedaliere ha detenuto una quota di mercato maggiore nel 2022.
In base al paese, il mercato europeo degli oppioidi è suddiviso in Regno Unito, Germania, Francia, Italia, Spagna e resto d\'Europa. Il Regno Unito ha dominato la quota di mercato degli oppioidi in Europa nel 2022.
Endo International plc, Mallinckrodt Plc, Neuraxpharm Pharmaceuticals SL, Hikma Pharmaceuticals Plc, Rusan Pharma Ltd e Teva Pharmaceutical Industries Ltd sono alcune delle aziende leader che operano nel mercato degli oppioidi in Europa.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - Europe Analysis
5.1 Europe Opioids Market Overview
5.2 Europe Opioids Market Revenue (US$ Million), 2020-2030
5.3 Europe Opioids Market Forecast Analysis
6. Europe Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. Europe Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Opioids Market - Country Analysis
10.1 Europe
10.1.1 Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.1.1 Europe: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.1.2 United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 United Kingdom: Europe Opioids Market Breakdown, by Product
10.1.1.2.2 United Kingdom: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.2.3 United Kingdom: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.2.4 United Kingdom: Europe Opioids Market Breakdown, by Application
10.1.1.2.5 United Kingdom: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.2.6 United Kingdom: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.3 Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Germany: Europe Opioids Market Breakdown, by Product
10.1.1.3.2 Germany: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.3.3 Germany: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.3.4 Germany: Europe Opioids Market Breakdown, by Application
10.1.1.3.5 Germany: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.3.6 Germany: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.4 France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 France: Europe Opioids Market Breakdown, by Product
10.1.1.4.2 France: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.4.3 France: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.4.4 France: Europe Opioids Market Breakdown, by Application
10.1.1.4.5 France: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.4.6 France: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.5 Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Italy: Europe Opioids Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.5.3 Italy: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.5.4 Italy: Europe Opioids Market Breakdown, by Application
10.1.1.5.5 Italy: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.5.6 Italy: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.6 Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Spain: Europe Opioids Market Breakdown, by Product
10.1.1.6.2 Spain: Europe Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.6.3 Spain: Europe Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.6.4 Spain: Europe Opioids Market Breakdown, by Application
10.1.1.6.5 Spain: Europe Opioids Market Breakdown, by Route of Administration
10.1.1.6.6 Spain: Europe Opioids Market Breakdown, by Distribution Channel
10.1.1.7 Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.7.1 Rest of Europe: Opioids Market Breakdown, by Product
10.1.1.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.7.4 Rest of Europe: Opioids Market Breakdown, by Application
10.1.1.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
10.1.1.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hikma Pharmaceuticals Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rusan Pharma Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Europe Opioids Market Segmentation
Table 2. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 13. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 25. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 31. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 33. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 35. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 36. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 37. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 38. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 39. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 40. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 41. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 42. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 43. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 44. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 45. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 46. Recent Organic Growth Strategies in Opioids Market
Table 47. Recent Inorganic Growth Strategies in the Opioids Market
Table 48. Glossary of Terms, Opioids Market
List of Figures
Figure 1. Europe Opioids Market Segmentation, by Country
Figure 2. Europe Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Europe Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Europe Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Europe: Opioids Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)
Figure 23. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. United Kingdom: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Germany: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. France: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Italy: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Spain: Europe Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Rest of Europe: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Growth Strategies in Opioids Market
- Endo International plc
- Mallinckrodt Plc
- Neuraxpharm Pharmaceuticals SL
- Hikma Pharmaceuticals Plc
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe opioids market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe opioids market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.